Board of Trustees Header

Eduardo C. Alfonso, MD, Chairman of the Department of Ophthalmology of the University of Miami Miller School of Medicine and director of the Bascom Palmer Eye Institute's patient care facilities, Anne Bates Leach Eye Hospital in Miami, and outpatient facilities in Palm Beach Gardens, Plantation and Naples, Florida, is one of the most recognized ophthalmologists in the world. Holder of the Edward W. D. Norton Professor of Ophthalmology, he is known for his clinical expertise in diseases and surgery of the cornea and ocular microbiology and laser vision correction. He has published numerous articles in refereed journals, chapters, and has been guest lecturer nationally and internationally. He is fellow of the American Academy of Ophthalmology where he has been awarded the distinguished honor award and senior honor award. He has been named as one of America's Top Doctors since 1992. Dr. Alfonso graduated summa cum laude from Yale University in 1976. He graduated from Yale Medical School in 1980. His ophthalmology residency was completed at the Bascom Palmer Eye Institute of the University of Miami School of Medicine. He completed fellowships in cornea and ocular pathology at the Massachusetts Eye and Ear Infirmary at Harvard Medical School.

Back to Board

Dr. Julia A. Haller, MD, is Ophthalmologist-in-Chief of the Wills Eye Institute, where she holds the William Tasman, M.D. Endowed Chair. She serves as Professor and Chair of the Department of Ophthalmology at Jefferson Medical College of Thomas Jefferson University and Thomas Jefferson University Hospitals. She was educated at the Bryn Mawr School in Baltimore, Princeton University, and Harvard Medical School. She was an ophthalmology resident, retina fellow, and the first female chief resident at the Wilmer Eye Institute at Johns Hopkins Hospital, and went on to hold both the Katharine Graham and Robert Bond Welch, M.D. Professorships there before assuming leadership at Wills.

Her honors include the Rolex Achievement Award (to a past participant in collegiate varsity lacrosse), the Crystal Apple Award of the American Society of Retina Specialists for teaching and mentorship, the Kreissig Award from EURETINA, the President's Award from Women in Ophthalmology, a Secretariat Award from the AAO, the Gertrude Pyron Award from the Retina Research Foundation and the ASRS, and a Lifetime Achievement Award from the AAO.

Dr. Haller has published over 250 papers in the peer reviewed literature as well as 22 book chapters. She is past president of the American Society of Retina Specialists, Vice-President and President Elect of the Retina Society, and a member of the Executive Committee of the Macula Society and the Board of Trustees of the Association of University Professors of Ophthalmology. She serves on the editorial boards of RETINA, Retinal Physician, Retina Times, Ocular Surgery News, Retina Today, Ophthalmology Times, EyeWorld, and Evidence-Based Eye Care.

Dr. Haller serves on the Board of the American Retina Foundation, the Board of the ARVO Foundation for Eye Research, and the Board of Trustees of Princeton University.

Back to Board

Paul P. Lee, MD, JD, serves as F. Bruce Fralick Professor and Chair in the Department of Ophthalmology at the University of Michigan Medical School and Director of the W.K. Kellogg Eye Center.

Dr. Lee has published over 250 papers on glaucoma and eye care delivery in general, particularly on understanding and improving eye and health care. He has been principal investigator on research projects to evaluate the appropriateness of cataract surgery, the quality of glaucoma and diabetic retinopathy care, utilization patterns of eye care, provider workforce analyses for ophthalmology and orthopedics, and analyses of failure patterns for the treatment of diabetes related eye disease and glaucoma. He has also led the ophthalmic portions of other projects investigating conformance with AHCPR guidelines for cataract, utilization and quality of eye care patterns in managed care, and a comparison of fee-for-service to managed care among Medicare patients.

Dr. Lee has served in several leadership capacities, including as the immediate past chair of the ARVO Foundation, an at-large member of the Board of Trustees of the American Academy of Ophthalmology (AAO), chair of the American Glaucoma Society’s Quality of Care Subcommittee, and original co-chair of the AMA-AAO Consortium Task Force for Eye Care Quality Indicators (PQRI). He has also been a consultant for the CDC and the WHO, as well as RAND. He currently serves on the Board of Advisors for the Hoskins Center on Patient Safety and Quality for the Foundation of the AAO and has served on the IRIS Registry Development Group, the first national outpatient care registry of any specialty being implemented in the United States. In addition, Dr. Lee serves as the vice-chair and chair-elect of the Board of Directors of the American Board of Ophthalmology, on the Board of Directors of the Association of University Professors of Ophthalmology and the American Glaucoma Society, and as a past board member of Prevent Blindness America, the Blind Children’s Center, and the Center for the Partially Sighted.

He has received the Lew Wasserman Merit Award from Research to Prevent Blindness, the Alcon Institute Research Award, the Senior Achievement Award from the AAO, the Gold Fellow from ARVO, and has been inducted into Academia Ophthalmologica Internationalis. He has also delivered the American Glaucoma Society Lecture, the Parker-Heath Lecture of the AMA section of ophthalmology, and the Shaffer Lecture at the American Academy of Ophthalmology.

Dr. Lee received his law degree from Columbia University in 1986. He received his medical degree from the University of Michigan that same year.

Back to Board

Russell Van Gelder, MD, PhD, was born and raised in and around New York City. He earned his BS, MD, and PhD (Neurosciences) degrees from Stanford University, where he also completed medical internship. He completed his ophthalmology residency and fellowship in uveitis and medical retinal disease at Barnes/Jewish Hospital, Washington University in St. Louis. During his fellowship year (1998-1999) Dr. Van Gelder was a Heed Fellow. He served on faculty at Washington University, St. Louis for nine years, and was named to the Bernard Becker chair. In 2008, Dr. Van Gelder moved to the University of Washington, where he is presently Boyd K. Bucey Memorial Chair of Ophthalmology, and director of the UW Medicine Eye Institute.

An active clinician-scientist, Dr. Van Gelder has been continually funded from the National Institutes of Health for the past 13 years. His laboratory has made seminal contributions to the understanding of non-visual ocular photoreception, and to pathogen discovery in ocular inflammatory disease. He has received numerous honors, including career development awards from Research to Prevent Blindness, the Culpeper Foundation, and the Burroughs-Wellcome Foundation. Dr. Van Gelder is author of over 100 scientific and medical publications, and holds five patents in biotechnology. He serves on several editorial boards including the American Journal of Ophthalmology and Investigative Ophthalmology and Vision Science. He has served as President of the American Uveitis Society, and presently serves on the Board of Trustees of the American Academy of Ophthalmology. He lives with his wife and two children on Mercer Island, Washington.

Back to Board

Dr. Zarbin graduated from Dartmouth College and the Johns Hopkins University School of Medicine. He completed resident and fellowship training (vitreoretinal surgery and medical retina) at the Wilmer Ophthalmological Institute and was an Assistant Chief of Service at Wilmer. Dr. Zarbin is Chair of the Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School and Chief of Ophthalmology at University Hospital in Newark, NJ. He is a Professor of Ophthalmology and Neuroscience and is the Alfonse A. Cinotti, MD/Lions Eye Research Chair. Dr. Zarbin is co-Director of the Ocular Cell Transplantation Laboratory. He has published 221 peer-reviewed papers and editorials, 100 book chapters, one book on age-related macular degeneration, one book on stem cell therapy for degenerative retinal disease, and two books on the management of diabetic retinopathy.

Dr. Zarbin is a Vice Chair of the Scientific Advisory Board of the Foundation Fighting Blindness, Editor-in-Chief of Translational Vision Science and Technology, is a member of the editorial board of Ophthalmology, Ophthalmology Retina, and the Journal of Vitreoretinal Diseases, and is an ex officio member of the National Advisory Eye Council. He is also a member of the American Ophthalmological Society, Academia Ophthalmologica Internationalis, the Retina Society, the Macula Society, the Club Jules Gonin, and the ASRS. Dr. Zarbin is listed among the “Best Doctors” by Castle Connolly. Dr. Zarbin is an ARVO Fellow, Gold Level and is a recipient of the Heed Award.

Back to Board